Merck & Co. Inc. (MRK)

$ 150.36
   
  • Change Today:
    $5.69
  • 52 Week High: $156.45
  • 52 Week Low: $83.86
  • Currency: US Dollars
  • Shares Issued: 2,474.63m
  • Volume: 10,698,575
  • Market Cap: $372,085m
  • RiskGrade: 92

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest ShareCast News

Moderna, MSD hail positive trial results for melanoma vaccine

By Michele Maatouk

Date: Friday 21 Aug 2026

(Sharecast News) - Pharmaceutlcal firms Moderna and MSD (Merck Sharp & Dohme (UK) Limited) said on on Wednesday that a personalised mRNA melanoma vaccine they are jointly developing had shown positive results in a first-ever late-stage trial.

Merck News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Merck Market Data

Currency US Dollars
Share Price $ 150.36
Change Today $ 5.69
% Change 3.93 %
52 Week High $156.45
52 Week Low $83.86
Volume 10,698,575
Shares Issued 2,474.63m
Market Cap $372,085m
RiskGrade 92

What The Brokers Say

Strong Buy 8
Buy 12
Neutral 7
Sell 0
Strong Sell 0
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 04-Nov-2026

Time Volume / Share Price
16:04 3,044,600 @ $150.36
16:00 22,224 @ $150.34
16:00 100 @ $150.34
16:00 100 @ $150.36
16:00 1,330 @ $150.36

Top of Page